PRO-DRUGS OF DOPAMINERGIC AGONISTS

被引:0
|
作者
HORN, AS
机构
关键词
D O I
暂无
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
引用
收藏
页码:441 / 443
页数:3
相关论文
共 50 条
  • [21] PREPARATION AND CHARACTERIZATION OF PRO-DRUGS OF THE PRAZIQUANTEL POTENTIALLY SCHISTOSOMICIDS
    DENARVAEZ, AJR
    ARAUJO, S
    [J]. ACTA CIENTIFICA VENEZOLANA, 1988, 39 (5-6): : 451 - 455
  • [22] ISOTHIAZOLONE BIOCIDES - ENZYME-INHIBITING PRO-DRUGS
    COLLIER, PJ
    AUSTIN, P
    GILBERT, P
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 74 (2-3) : 195 - 201
  • [23] Synthesis and characterization of aminoacidic pro-drugs of valproic acid
    Giannola, LI
    Lamartina, L
    de Caro, V
    [J]. PHARMAZIE, 1998, 53 (12): : 829 - 834
  • [24] PRO-DRUGS FOR THE ORAL DELIVERY OF DISODIUM-CROMOGLYCATE
    MORI, T
    NISHIMURA, K
    TAMAKI, S
    NAKAMURA, S
    TSUDA, H
    KAKEYA, N
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1988, 36 (01) : 338 - 344
  • [25] WHAT ARE THE MECHANISMS BY WHICH PRO-DRUGS ARE ACTIVATED IN THE BODY
    BUNDGAARD, H
    [J]. JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1983, 8 (02): : 153 - 154
  • [26] Cobalt (III) Complexes as Pro-drugs for Cancer Therapy
    Zhang, Chen
    Sutherland, Mathew
    Chiang, Linus
    Clarke, Ryan
    Thompson, John
    Walsby, Charles
    Storr, Timothy
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [27] PRO-DRUGS AND 1ST-PASS EFFECTS
    JOHNSON, P
    [J]. CHEMISTRY & INDUSTRY, 1980, (11) : 443 - 447
  • [28] Synthesis of naproxen pro-drugs for enhanced transdermal absorption
    [J]. Assali, Mohyeddin, 1600, Journal of Chemical and Pharmaceutical Research, 3/668 Malviya Nagar, Jaipur, Rajasthan, India (06):
  • [29] RENAL PRO-DRUGS OFFER NEW PERSPECTIVES IN IMMUNOSUPPRESSIVE THERAPY
    RUERS, TJM
    BUURMAN, WA
    VANDERLINDEN, CJ
    VANDONGEN, JJ
    KOOTSTRA, G
    [J]. TRANSPLANTATION PROCEEDINGS, 1986, 18 (04) : 907 - 909
  • [30] EFFECTS OF CYSTEINE PRO-DRUGS ON ACETAMINOPHEN-INDUCED HEPATOTOXICITY
    HAZELTON, GA
    HJELLE, JJ
    KLAASSEN, CD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 237 (01): : 341 - 349